| Lutetium (177Lu) chloride Billev 51.8 GBq/mL radiopharmaceutical precursor, solution EU/1/22/1680/001-006 |
Lutetium (177lu) chloride |
Billev Pharma ApS |
— |
| Lutinus 100 mg vaginal tablets PA1009/022/001 |
Progesterone |
Ferring Ireland Ltd |
Marketed |
| Luveris EU/1/00/155/001 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris EU/1/00/155/002 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris EU/1/00/155/003 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris EU/1/00/155/007 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris 75 IU powder and solvent for solution for injection EU/1/00/155/004 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris 75 IU powder and solvent for solution for injection EU/1/00/155/005 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luveris 75 IU powder and solvent for solution for injection EU/1/00/155/006 |
Lutropin alfa |
Merck Europe B.V. |
— |
| Luxturna 5 × 1012 vector genomes/mL concentrate and solvent for solution for injection EU/1/18/1331/001 |
VORETIGENE NEPARVOVEC |
Novartis Ireland Limited |
— |
| Lycimor 300 mg Capsules, Hard PA1986/118/001 |
Lymecycline |
Teva B.V. |
Marketed |
| Lyclear 5% w/w Dermal Cream PA1077/066/001 |
Permethrin |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Lyclear Creme Rinse 1% w/w Cutaneous solution PA1186/003/001 |
Permethrin |
Chefaro Ireland DAC |
Marketed |
| Lydisilka 3 mg/14.2 mg film-coated tablets EU/1/21/1548/001-004 |
Estetrol monohydrate, Estetrol, Drospirenone |
Estetra |
— |
| LYFNUA 45 mg Film-coated tablet EU/1/21/1613/001-004 |
Gefapixant |
Merck Sharp & Dohme BV, |
— |
| LYNOZYFIC 200 mg concentrate for solution for infusion EU/1/25/1917/002 |
Linvoseltamab |
Regeneron Ireland Designated Activity Company |
— |
| LYNOZYFIC 5 mg concentrate for solution for infusion EU/1/25/1917/001 |
Linvoseltamab |
Regeneron Ireland Designated Activity Company |
— |
| Lynparza 100 mg Film-coated tablet EU/1/14/959/002-003 |
Olaparib |
AstraZeneca AB |
— |
| Lynparza 150 mg Film-coated tablet EU/1/14/959/004-005 |
Olaparib |
AstraZeneca AB |
— |
| Lyrica 100 mg hard capsules EU/1/04/279/014-016 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 150 mg hard capsules EU/1/04/279/017-019 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 150 mg orodispersible tablets EU/1/04/279/053-055 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 20 mg/ml oral solution EU/1/04/279/044 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 200 mg hard capsules EU/1/04/279/020-022 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 225 mg hard capsules EU/1/04/279/033-035 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 25 mg hard capsules EU/1/04/279/001-005 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 25 mg orodispersible tablets EU/1/04/279/047-049 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 300 mg hard capsules EU/1/04/279/023-025 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 50 mg hard capsules EU/1/04/279/006-010 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 75 mg hard capsules EU/1/04/279/011-013 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 75 mg orodispersible tablets EU/1/04/279/050-052 |
Pregabalin |
Upjohn EESV |
— |
| LysaKare 25 g/25 g Solution for infusion EU/1/19/1381/001 |
L-lysine hydrochloride, L-arginine hydrochloride |
Advanced Accelerator Applications |
— |
| Lysodren 500mg tablets EU/1/04/273/001 |
Mitotane |
Esteve Pharmaceuticals S.A. |
— |
| Lytenava 25 mg/mL solution for injection EU/1/24/1798/001 |
Bevacizumab |
Outlook Therapeutics NL B.V. |
— |
| Lytgobi 4 mg film-coated tablet EU/1/23/1741/001-003 |
Futibatinib |
Taiho Pharma Netherlands B.V. |
— |
| Lyumjev EU/1/20/1422/001-012 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Lyvdelzi 10 mg hard capsules EU/1/24/1898/001 |
Seladelpar lysine dihydrate |
Cymabay Ireland Limited |
— |